Virtu Financial LLC Alzamend Neuro, Inc. Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	SELL	$0.49 - $0.77 $22,803 - $35,833	-46,537 Reduced 68.59%	21,309 $11,000
Q1 2023 May 01, 2023	BUY	$0.37 - $0.71 $1,918 - $3,682	5,186 Added 8.28%	67,846 $29,000
Q4 2022 Feb 15, 2023	BUY	$0.53 - $222.0 $33,209 - $13.9 Million	62,660 New	62,660 $35,000
Q1 2022 May 17, 2022	SELL	$0.91 - $2.23 $21,001 - $51,466	-23,079 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$1.9 - $3.08 $43,850 - $71,083	23,079 New	23,079 $44,000
Q3 2021 Nov 12, 2021	SELL	$2.28 - $7.68 $35,116 - $118,287	-15,402 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$8.12 - $13.5 $125,064 - $207,927	15,402 New	15,402 $135,000

Ticker ALZN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 95,481,800
Market Cap $115M
Description
Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001 that is in Phase II clinical trial, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.